Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Molecure SA (1B1.MU)

1.9700
0.0000
(0.00%)
As of 8:04:09 AM GMT+2. Market Open.
Currency in PLN All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
0.1000
--
0.4000
Cost of Revenue
3,409.0090
3,409.0090
4,101.7100
1,634.5660
2,773.4900
Gross Profit
-3,409.0090
-3,409.0090
-4,101.6100
-1,634.5660
-2,773.0900
Operating Expense
28,893.1560
28,893.1560
28,026.4350
15,352.8360
10,991.2090
Operating Income
-32,302.1650
-32,302.1650
-32,128.0450
-16,987.4020
-13,764.2990
Net Non Operating Interest Income Expense
1,031.1590
1,031.1590
4,297.1630
1,792.9490
-6.4740
Pretax Income
-31,287.9280
-31,287.9280
-28,373.1170
-15,263.6970
-13,636.3190
Net Income Common Stockholders
-31,287.9280
-31,287.9280
-28,373.1170
-15,263.6970
-13,636.3190
Diluted NI Available to Com Stockholders
-31,287.9280
-31,287.9280
-28,373.1170
-15,263.6970
-13,636.3190
Basic EPS
-1.23
-1.55
-1.69
-1.09
-0.98
Diluted EPS
-1.23
-1.55
-1.69
-1.09
-0.98
Basic Average Shares
16,836
20,203.2000
16,836
14,030
13,951.5710
Diluted Average Shares
16,836
20,203.2000
16,836
14,030
13,955.8950
Total Operating Income as Reported
-32,302.1650
-32,302.1650
-32,128.0450
-16,987.4020
-13,764.2990
Total Expenses
32,302.1650
32,302.1650
32,128.1450
16,987.4020
13,764.6990
Net Income from Continuing & Discontinued Operation
-31,287.9280
-31,287.9280
-28,373.1170
-15,263.6970
-13,636.3190
Normalized Income
-31,287.9280
-31,287.9280
-28,373.1170
-15,263.6970
-13,636.3190
Interest Income
1,125.3920
1,125.3920
4,389.7330
1,911.2230
0.0010
Interest Expense
0.0900
0.0900
0.0010
16.3570
6.2370
Net Interest Income
1,031.1590
1,031.1590
4,297.1630
1,792.9490
-6.4740
EBIT
-31,287.8380
-31,287.8380
-28,373.1160
-15,247.3400
-13,630.0820
EBITDA
-27,468.0450
-27,468.0450
-24,493.0330
-13,934.1850
-13,330.2650
Reconciled Cost of Revenue
3,409.0090
3,409.0090
4,101.7100
1,634.5660
2,773.4900
Reconciled Depreciation
3,819.7930
3,819.7930
2,826.1580
1,313.1550
299.8170
Net Income from Continuing Operation Net Minority Interest
-31,287.9280
-31,287.9280
-28,373.1170
-15,263.6970
-13,636.3190
Normalized EBITDA
-27,468.0450
-27,468.0450
-24,493.0330
-13,934.1850
-13,330.2650
12/31/2021 - 4/20/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0VQ0.F PureTech Health plc
13.70
+0.74%
 
6YG.MU Immunocore Holdings plc
26.40
-1.49%
 
PHR.WA Pharmena S.A.
4.3100
0.00%
 
6YG.BE Immunocore Holdings PLC
26.40
-2.22%
 
OXOA.BE Oxford BioMedica PLC
3.5600
-0.56%
 
PQB.MU Pure Biologics SA
2.4140
0.00%
 
9Y4.SG Ryvu Therapeutics SA
7.39
-2.64%
 
PQB.F Pure Biologics S.A.
2.0560
+1.48%
 
URT.WA Urteste S.A.
82.00
+2.50%
 
XI3.F Bioceltix S.A.
23.20
+1.75%